Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Bancroft

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|December 17, 2013
Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011Ashley Fowlkes, Andrea Giorgi, Dean Erdman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 24, 2020
Task Shifting for Initiation and Monitoring of Antiretroviral Therapy for HIV-Infected Adults in Uganda: The SHARE TrialBrian Arthur Sekiziyivu, Elizabeth Bancroft, Evelyn M Rodriguez, et al.
International Journal of Cancer|June 22, 2007
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibilityJulian Barwell, Laurent Pangon, Anne Georgiou, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate CancerTommy Nyberg, Mark N Brook, Lorenzo Ficorella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
BMC Medical Education|April 8, 2021
Standardizing clinical culture specimen collection in Ethiopia: a training-of-trainersJennifer Kue, Ashley Bersani, Kurt Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Emerging Infectious Diseases|December 11, 2022
Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East AfricaDanica J Gomes, Carmen Hazim, Jacqueline Safstrom, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|December 17, 2013
Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011Ashley Fowlkes, Andrea Giorgi, Dean Erdman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 24, 2020
Task Shifting for Initiation and Monitoring of Antiretroviral Therapy for HIV-Infected Adults in Uganda: The SHARE TrialBrian Arthur Sekiziyivu, Elizabeth Bancroft, Evelyn M Rodriguez, et al.
International Journal of Cancer|June 22, 2007
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibilityJulian Barwell, Laurent Pangon, Anne Georgiou, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2022
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate CancerTommy Nyberg, Mark N Brook, Lorenzo Ficorella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
BMC Medical Education|April 8, 2021
Standardizing clinical culture specimen collection in Ethiopia: a training-of-trainersJennifer Kue, Ashley Bersani, Kurt Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Emerging Infectious Diseases|December 11, 2022
Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East AfricaDanica J Gomes, Carmen Hazim, Jacqueline Safstrom, et al.
Pageof 6